Cytomegalovirus (CMV) Hyperimmune Globulin from Japan
Hyperimmune plasma fraction enriched with CMV-specific antibodies for preventing CMV infection in transplant patients. Falls under HTS 3002.12.0090 as an other blood fraction/antisera prepared for prophylactic use through plasma fractionation. It meets the definition of immunological products from human blood.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide viral safety dossiers (e.g
• PCR negative for CMV, HIV) as required for blood product imports
• Label as 'human origin' with donor screening records to pass FDA review
• Avoid bulk import without fractionation proof; could misclassify as raw plasma